Correct Answer: B. Infiltration of subdermal lymphatics
The clinical presentation describes peau d'orange (orange peel skin), a pathognomonic sign of advanced breast cancer. This occurs when malignant cells infiltrate the subdermal lymphatic vessels, causing lymphatic obstruction and subsequent dermal edema. The lymphatic channels in the breast drain toward the axilla and internal mammary nodes; when tumor cells block these vessels, fluid accumulates in the dermis, creating the characteristic dimpled appearance. The skin dimples at hair follicles because the follicles are anchored to deeper structures by fibrous tissue, while the intervening skin between follicles becomes edematous and elevated. This is a T4b disease (skin involvement) per TNM staging and indicates locally advanced cancer requiring multimodal therapy (neoadjuvant chemotherapy, surgery, and radiation). The key discriminator is that peau d'orange results from lymphatic obstruction, not direct tumor invasion of the dermis or involvement of structural ligaments. In Indian clinical practice, this sign often prompts urgent staging and discussion of palliative versus curative intent, as it significantly worsens prognosis.
Why the other options are wrong
A. Spread of the tumor to the anterior chest wall — Direct invasion of the chest wall (T4c disease) causes fixation of the breast to the wall and ulceration, not peau d'orange. Peau d'orange is a superficial dermal phenomenon caused by lymphatic obstruction, not deep invasion. This option confuses advanced local disease with the specific mechanism of skin dimpling. C. Infiltration of the lactiferous duct — Lactiferous duct involvement causes nipple discharge (bloody or serous) and may lead to Paget's disease of the nipple, not peau d'orange. Duct infiltration is a central phenomenon, whereas peau d'orange is a diffuse dermal finding caused by lymphatic obstruction. This is an NBE trap pairing breast cancer with a different skin sign. D. Involvement of Cooper's ligament — Cooper's ligaments are fibrous septa anchoring breast tissue to the chest wall; their involvement causes skin dimpling or retraction at specific points (dimple sign), not the diffuse peau d'orange pattern. Peau d'orange is generalized edema from lymphatic blockade, whereas Cooper's ligament involvement produces focal dimpling. This option confuses two distinct skin signs.
High-Yield Facts
- Peau d'orange = subdermal lymphatic obstruction by tumor cells; pathognomonic for T4b breast cancer.
- T4b disease = skin involvement (peau d'orange, ulceration, nodules); TNM staging indicates locally advanced cancer.
- Lymphatic obstruction causes dermal edema at hair follicles (anchored to deeper structures), creating the dimpled orange-peel appearance.
- Dimple sign (focal retraction) ≠ peau d'orange (diffuse edema); dimples result from Cooper's ligament involvement or skin tethering.
- Paget's disease of nipple = lactiferous duct infiltration; presents with nipple eczema and discharge, not peau d'orange.
- Indian DOC for T4b breast cancer = neoadjuvant chemotherapy (anthracycline + taxane) followed by surgery and radiation; 5-year survival ~40–50%.
Mnemonics
PEAU D'ORANGE Mechanism Peripheral lymphatic Obstruction → Dermal Edema → Orange-peel Retraction at Anchor points (hair follicles) → Not direct Growth → Edema pattern T4 Breast Cancer Skin Signs T4a = Chest wall invasion (fixation); T4b = Skin involvement (peau d'orange, ulceration, satellite nodules). Remember: T4b = Blotchy/diffuse skin changes (lymphatic), T4a = Anchored/fixed (deep invasion).
NBE Trap
NBE pairs breast cancer with multiple skin signs (peau d'orange, dimple sign, Paget's disease) to test whether students can discriminate the mechanism (lymphatic obstruction vs. ligament tethering vs. duct involvement) rather than just naming the sign. The trap is choosing "chest wall invasion" or "Cooper's ligament" because they sound like advanced disease.
Clinical Pearl
In Indian breast cancer clinics, peau d'orange is often the first sign that prompts patients to seek care, but by then the disease is locally advanced. Early recognition and urgent referral for neoadjuvant chemotherapy can downstage the tumor and improve surgical resectability—a critical intervention in resource-limited settings where delayed presentation is common.
_Reference: Bailey & Love Ch. 52 (Breast); Robbins Ch. 24 (Breast Pathology); Harrison Ch. 375 (Breast Cancer)_